Similarly, both the insulin receptor substrate-1 (IRS-1) and PDK1, two components of the IGF-1R pathway, showed reduced phosphorylation in NSCLC U-1810 cells upon treatment with either of the two compounds (Figure 1B). This evidence concerns the gene IGF1R and non-small cell lung carcinoma.